| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.2M | +18.9% |
| SG&A Expense | $18.9M | +53.2% |
| Operating Income | -$45.1M | -26.5% |
| Income Tax | $0 | — |
| Net Income | -$45.2M | +4.7% |
| EPS (Basic) | -$1.72 | +59.4% |
| EPS (Diluted) | -$1.72 | +59.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.6M | -7.1% |
| Short-term Investments | $80.0M | -10.7% |
| Current Assets | $134.4M | -9.3% |
| Total Assets | $135.0M | -22.1% |
| Current Liabilities | $6.1M | +1.1% |
| Total Liabilities | $6.3M | +4.0% |
| Stockholders' Equity | $128.7M | -23.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.4M | -3.6% |
| Investing Cash Flow | $34.4M | +130.0% |
| Financing Cash Flow | $0 | -100.0% |